Alembic Pharmaceuticals Limited(IN:APLLTD)
₹1,055.80+26.10 (+2.53%)
IN:APLLTD
Alembic Pharmaceuticals Limited financials statements
₹1,055.80
At close:+26.10 (+2.53%)
Want to see IN:APLLTD full AI Analyst Report?
Alembic Pharmaceuticals Limited (APLLTD) Financial Statements
2 Followers
Alembic Pharmaceuticals Limited Financial Overview
Alembic Pharmaceuticals Limited's market cap is currently ₹202.40B. The company's EPS TTM is ₹42.92; its P/E ratio is 24.00; and it has a dividend yield of 1.16%. Alembic Pharmaceuticals Limited is estimated to report earnings on February 11, 2027, and the estimated EPS forecast is ₹10.35. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 73.45B | ₹ 66.72B | ₹ 62.29B | ₹ 56.53B | ₹ 53.06B |
| Gross Profit | ₹ 33.10B | ₹ 47.91B | ₹ 44.33B | ₹ 38.78B | ₹ 38.08B |
| Operating Income | ₹ 8.00B | ₹ 27.02B | ₹ 25.08B | ₹ 19.81B | ₹ 18.31B |
| EBITDA | ₹ 11.06B | ₹ 10.08B | ₹ 9.33B | ₹ 7.13B | ₹ 8.74B |
| Net Income | ₹ 6.75B | ₹ 5.83B | ₹ 6.16B | ₹ 3.42B | ₹ 5.21B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 2.03B | ₹ 901.00M | ₹ 1.20B | ₹ 754.80M | ₹ 610.90M |
| Total Assets | ₹ 87.63B | ₹ 77.73B | ₹ 64.46B | ₹ 61.83B | ₹ 71.22B |
| Total Debt | ₹ 14.30B | ₹ 12.57B | ₹ 5.13B | ₹ 7.22B | ₹ 7.17B |
| Net Debt | ₹ 12.27B | ₹ 11.67B | ₹ 3.93B | ₹ 6.47B | ₹ 6.56B |
| Total Liabilities | ₹ 30.94B | ₹ 25.83B | ₹ 16.27B | ₹ 18.12B | ₹ 18.84B |
| Stockholders' Equity | ₹ 56.75B | ₹ 51.91B | ₹ 48.18B | ₹ 43.70B | ₹ 52.38B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 2.61B | ₹ -4.76B | ₹ 4.76B | ₹ 2.81B | ₹ 1.27B |
| Operating Cash Flow | ₹ 6.95B | ₹ 879.70M | ₹ 8.03B | ₹ 7.24B | ₹ 5.52B |
| Investing Cash Flow | ₹ -5.07B | ₹ -5.68B | ₹ -3.21B | ₹ -4.48B | ₹ -3.72B |
| Financing Cash Flow | ₹ -756.50M | ₹ 4.44B | ₹ -4.38B | ₹ -2.62B | ₹ -2.17B |
Currency in INR

